Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level

Volume: 43, Issue: 3, Pages: 464 - 471
Published: Mar 30, 2019
Abstract
Toxoplasma gondii is an opportunistic parasite causing life-threatening diseases in immune-compromised patients. The purpose of the study is to determine the seroprevalence of Toxoplasma gondii in chemotherapy receiving cancer patients in relation to different types of malignancies, and to estimate the level of interferon gamma in Toxoplasma seropositive and seronegative cancer patients and healthy controls. Anti-Toxoplasma IgG and IgM...
Paper Details
Title
Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level
Published Date
Mar 30, 2019
Volume
43
Issue
3
Pages
464 - 471
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.